Michael Rosenblatt Azenta, Inc. (AZTA) insider trading activity

Michael Rosenblatt is of Azenta, Inc.. Currently has a direct ownership of 13,042 shares of AZTA, which is worth approximately $657,708. The most recent transaction as insider was on Feb 12, 2024, when has been sold 2,465 shares (Common) at a price of $65.93 per share, resulting in proceeds of $162,517. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 13K

0% 3M change

23.31% 12M change

Total Value Held $657,708

Michael Rosenblatt Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 12 2024	BUY Grant, award, or other acquisition	$162,517 $65.93 p/Share	2,465 Added 15.9%	13,042 Common
Feb 13 2023	BUY Grant, award, or other acquisition	-	3,604 Added 25.41%	10,577 Common Stock
Feb 11 2022	BUY Grant, award, or other acquisition	-	1,922 Added 21.61%	6,973 Common Stock
Nov 12 2021	SELL Open market or private sale	$323,102 $114.13 p/Share	2,831 Reduced 35.92%	5,051 Common Stock
May 13 2021	SELL Open market or private sale	$158,400 $90.0 p/Share	1,760 Reduced 18.25%	7,882 Common Stock
Feb 05 2021	BUY Grant, award, or other acquisition	-	1,760 Added 15.44%	9,642 Common Stock

Also insider at

MRK

Merck & Co., Inc. Healthcare

Exec V-P & Chief Med Officer

AXLA

Axcella Health Inc. Healthcare

Director

RUBY

Rubius Therapeutics, Inc. Healthcare

Director